Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia
Clinical trial NCT07491263 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07491263
- Sponsor
- Fujian Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-04-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.